Evidence map›Paper›PMID 30830424›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2019

Development of a rapid profiling method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS.

Adam M King, Lauren G Mullin, Ian D Wilson, Muireann Coen, Paul D Rainville, Robert S Plumb, Lee A Gethings, Garth Maker, Robert Trengove

Open access · hybridAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Adam M KingWaters Corporation, SK9 4AX, Wilmslow, Cheshire, UK.ORCID 0000-0002-0819-2874
Lauren G MullinWaters Corporation, 01757, Milford, MA, USA.ORCID 0000-0001-5560-933X
Ian D WilsonComputational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK. i.wilson@imperial.ac.uk.ORCID 0000-0002-8558-7394
Muireann CoenComputational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Paul D RainvilleSeparations Science and Metabolomics laboratory, Murdoch University, South Street, 6150, Murdoch, WA, Australia.
Robert S PlumbSeparations Science and Metabolomics laboratory, Murdoch University, South Street, 6150, Murdoch, WA, Australia.ORCID 0000-0002-1380-9285
Lee A GethingsWaters Corporation, SK9 4AX, Wilmslow, Cheshire, UK.ORCID 0000-0003-3513-364X
Garth MakerMedical and Molecular Sciences, School of Veterinary and Life Sciences, Murdoch University, South Street, 6150, Murdoch, WA, Australia.
Robert TrengoveSeparations Science and Metabolomics laboratory, Murdoch University, South Street, 6150, Murdoch, WA, Australia.
Murdoch University · AUAstraZeneca (United Kingdom) · GBImperial College London · GBWaters (United Kingdom) · GBWaters (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAs large scale metabolic phenotyping is increasingly employed in preclinical studies and in the investigation of human health and disease the current LC-MS/MS profiling methodologies adopted for large sample sets can result in lengthy analysis times, putting strain on available resources. As a result of these pressures rapid methods of untargeted analysis may have value where large numbers of samples require screening.

objectivesTo develop, characterise and evaluate a rapid UHP-HILIC-MS-based method for the analysis of polar metabolites in rat urine and then extend the capabilities of this approach by the addition of IMS to the system.

methodsA rapid untargeted HILIC LC-MS/MS profiling method for the analysis of small polar molecules has been developed. The 3.3 min separation used a Waters BEH amide (1 mm ID) analytical column on a Waters Synapt G2-Si Q-Tof enabled with ion mobility spectrometry (IMS). The methodology, was applied to the metabolic profiling of a series of rodent urine samples from vehicle-treated control rats and animals administered tienilic acid. The same separation was subsequently linked to IMS and MS to evaluate the benefits that IMS might provide for metabolome characterisation.

resultsThe rapid HILIC-MS method was successfully applied to rapid analysis of rat urine and found, based on the data generated from the data acquired for the pooled quality control samples analysed at regular intervals throughout the analysis, to be robust. Peak area and retention times for the compounds detected in these samples showed good reproducibility across the batch. When used to profile the urine samples obtained from vehicle-dosed control and those administered tienilic acid the HILIC-MS method detected 3007 mass/retention time features. Analysis of the same samples using HILIC-IMS-MS enabled the detection of 6711 features. Provisional metabolite identification for a number of compounds was performed using the high collision energy MS/MS information compared against the Metlin MS/MS database and, in addition, both calculated and measured CCS values from an experimentally derived CCS database.

conclusionA rapid metabolic profiling method for the analysis of polar metabolites has been developed. The method has the advantages of speed and both reducing sample and solvent consumption compared to conventional profiling methods. The addition of IMS added an additional dimension for feature detection and the identification of metabolites.

Indexed as

AnimalsBody FluidsChromatography, High Pressure LiquidChromatography, LiquidHigh-Throughput Screening AssaysHumansMaleMetabolomeMetabolomicsQuality ControlRatsRats, Sprague-DawleyReproducibility of ResultsTandem Mass SpectrometryUrineHydrophilic interaction chromatographyIMSLC–MS/MSMetabolic phenotyping

Identifiers

PMID30830424
PMCPMC6342856
OpenAlexW2914550005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.